Laval, Quebec, Canada-based Valeant Pharmaceuticals has named Joseph Papa CEO after he resigned from Allegan, Mich.-based Perrigo, according to Reuters.
In March, Valeant announced J. Michael Pearson, who had served as CEO since 2008, would step down from his post. Mr. Pearson will remain in his position until Mr. Papa takes over in early May.
Mr. Papa resigned as chairman and CEO of drugmaker Perrigo on April 24. He's been replaced by Perrigo President John Hendrickson.
Mr. Papa, who has also been pegged to serve on Valeant's board, had served as Perrigo's CEO since 2006 and as chairman since 2007, according to The Wall Street Journal. Prior to his time there, he was CEO and chairman of the technology services segment of Dublin, Ohio-based Cardinal Health.